The global Remicade Biosimilars Market is estimated to be valued at US$ 3007 million in 2023 and is expected to exhibit a CAGR of 3.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis
Strength: Remicade biosimilars are nearly identical versions of original biologic drugs and provide a more...
The global sulfasalazine market is estimated to be valued at US$ 2.32 Bn in 2024 and is expected to exhibit a CAGR of 18% over the forecast period 2024 to 2031.
SWOT Analysis
Strength: Sulfasalazine is a highly effective treatment for rheumatoid arthritis and inflammatory bowel diseases like ulcerative colitis. It is prescribed generically and is very affordable...